111 related articles for article (PubMed ID: 11205844)
1. Treatment of superior vena cava syndrome with recombinant tissue plasminogen activator in a sickle cell patient undergoing bone marrow transplantation.
Ramdas J; Haymon M; Ward K; Velez M; Yu LC
Pediatr Hematol Oncol; 2001; 18(1):71-7. PubMed ID: 11205844
[TBL] [Abstract][Full Text] [Related]
2. Superior vena cava syndrome arising from subclavian vein port catheter implantation and paraneoplastic syndrome.
Dağdelen S
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):125-7. PubMed ID: 19404035
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
Simpson DR; Browett PJ; Doak PB; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
[TBL] [Abstract][Full Text] [Related]
4. [Use of recombinant tissue plasminogen activator (rt-PA) in occluding thrombosis of a Hickman catheter after bone marrow transplantation: clinical and coagulation physiologic aspects].
Eckhof-Donovan S; Michelmann I; Nürnberger W; Stieh J; Rost B; Kemperdick H; Göbel U
Klin Padiatr; 1993; 205(6):435-9. PubMed ID: 8309209
[TBL] [Abstract][Full Text] [Related]
5. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
Schranz D; Haugwitz D; Zimmer B; Schumacher R
Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
[TBL] [Abstract][Full Text] [Related]
6. Use of tissue type plasminogen activator in neonates: case reports and review of the literature.
Smets K; Vanhaesebrouck P; Voet D; Schelstraete P; Govaert P
Am J Perinatol; 1996 May; 13(4):217-22. PubMed ID: 8724722
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.
Goldberg SL; Shubert J; Rao AK; Redei I; Klumpp TR; Mangan KF
Bone Marrow Transplant; 1996 Sep; 18(3):633-6. PubMed ID: 8879629
[TBL] [Abstract][Full Text] [Related]
8. Superior vena cava syndrome (SVC syndrome): a rare cause of conjunctival suffusion.
Saeed AI; Schwartz AP; Limsukon A
Mt Sinai J Med; 2006 Dec; 73(8):1082-5. PubMed ID: 17285199
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic treatment of superior vena cava syndrome, a complication of a central venous catheter].
Wolters J; Berg H; Zeidler T
Anaesthesist; 1989 Jan; 38(1):40-3. PubMed ID: 2919751
[TBL] [Abstract][Full Text] [Related]
10. "The Scalpel or the Needle for Superior Vena Cava syndrome"?
Chandra D; Pothineni NV; Meena N
J Ark Med Soc; 2015 Aug; 112(3):34-5. PubMed ID: 26376553
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
Leahey AM; Bunin NJ
Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis.
Tan H; Kizilkaya M; Alper F; Becit N; Kürşat H
Acta Paediatr; 2005 Feb; 94(2):239-41. PubMed ID: 15981762
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic (rt-PA) therapy for superior vena cava thrombosis in a multiple trauma patient.
Imberti R; Albertario F; Bellinzona G; Dionigi RV; Preseglio I; Mapelli A
Acta Anaesthesiol Belg; 1991; 42(4):233-6. PubMed ID: 1796733
[TBL] [Abstract][Full Text] [Related]
14. [Iatrogenic superior vena cava syndrome. Successful thrombolysis with recombinant tissue plasminogen activator (r-tPA)].
Sternlo JE; Askelöf N
Lakartidningen; 1992 Jan; 89(4):214-5. PubMed ID: 1734155
[No Abstract] [Full Text] [Related]
15. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of superior vena cava syndrome with urokinase in an infant with a central venous catheter.
Caglar MK; Tolboom J
Helv Paediatr Acta; 1989 Jun; 43(5-6):483-6. PubMed ID: 2501237
[TBL] [Abstract][Full Text] [Related]
17. Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate.
Patton DF; Harper JL; Wooldridge TN; Gordon BG; Coccia P; Haire WD
Bone Marrow Transplant; 1996 Mar; 17(3):443-7. PubMed ID: 8704704
[TBL] [Abstract][Full Text] [Related]
18. Treatment of superior vena cava (SVC) syndrome and inferior vena cava (IVC) thrombosis in a patient with colorectal cancer: combination of SVC stenting and IVC filter placement to palliate symptoms and pave the way for port implantation.
Sauter A; Triller J; Schmidt F; Kickuth R
Cardiovasc Intervent Radiol; 2008 Jul; 31 Suppl 2():S144-8. PubMed ID: 17605068
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis of the superior vena cava due to a Hickman catheter: successful management by rt-PA thrombolysis.
Zaccone G; Pafundi PD; Veneziani A; Verbo A; Colli R
J Vasc Access; 2017 Nov; 18(6):e92-e94. PubMed ID: 28777397
[TBL] [Abstract][Full Text] [Related]
20. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.
Greenberg S; Kosinski R; Daniels J
Chest; 1991 May; 99(5):1298-301. PubMed ID: 1902161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
